Valerie Morisset Eliem Therapeutics, Inc. (ELYM) insider trading activity

ELYM Quotes by TradingView

Valerie Morisset is EVP, R&D AND CSO of Eliem Therapeutics, Inc.. Currently has a direct ownership of 505,307 shares of ELYM, which is worth approximately $3.9 Million. The most recent transaction as insider was on Apr 05, 2024, when has been sold 17,847 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 505K
3.66% 3M change
8.26% 12M change
Total Value Held $3.9 Million

Valerie Morisset Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 05 2024
BUY
Exercise of conversion of derivative security
-
17,847 Added 3.41%
505,307 Common Stock
Sep 20 2023
BUY
Exercise of conversion of derivative security
-
20,728 Added 4.08%
487,460 Common Stock
Mar 10 2023
BUY
Exercise of conversion of derivative security
-
316,410 Added 40.4%
466,732 Common Stock
VM

Valerie Morisset

EVP, R&D AND CSO
Redmond, WA

Track Institutional and Insider Activities on ELYM

Follow Eliem Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

News

Receive news related to Eliem Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELYM